99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with …
S Vallabhajosula, A Nikolopoulou… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
[PDF][PDF] 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and …
S Vallabhajosula, A Nikolopoulou… - J Nucl …, 2014 - rdcms-snmmi.s3.amazonaws.com
Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
[PDF][PDF] 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and …
S Vallabhajosula, A Nikolopoulou, JW Babich… - J Nucl Med, 2014 - academia.edu
Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: Pharmacokinetics and biodistribution studies in healthy subjects and patients with …
S Vallabhajosula, A Nikolopoulou… - Journal of Nuclear …, 2014 - pure.johnshopkins.edu
Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with …
S Vallabhajosula, A Nikolopoulou… - Journal of Nuclear …, 2014 - europepmc.org
Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
[PDF][PDF] 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and …
S Vallabhajosula, A Nikolopoulou, JW Babich… - J Nucl …, 2014 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
[PDF][PDF] 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and …
S Vallabhajosula, A Nikolopoulou, JW Babich… - J Nucl …, 2014 - researchgate.net
Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
[引用][C] 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and …
S Vallabhajosula, A Nikolopoulou, JW Babich… - Journal of Nuclear …, 2014 - cir.nii.ac.jp
<sup>99m</sup>Tc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane
Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients …
Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients …
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with …
S Vallabhajosula, A Nikolopoulou… - Journal of nuclear …, 2014 - pubmed.ncbi.nlm.nih.gov
Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
[PDF][PDF] 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and …
S Vallabhajosula, A Nikolopoulou, JW Babich… - J Nucl Med, 2014 - academia.edu
Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …